65 reports

  • A: CAUSES OF HEPATITIS B
  • Hepatitis B Drugs Pipeline

Top ## players hold majority of stake in the market ##.

  • Hepatitis
  • World
  • Market Size
  • AbbVie Inc.
  • Bristol-Myers Squibb Company

Therefore, low accessibility due to the high cost of hepatitis B treatment is one the biggest challenges for the goal aiming to eliminate hepatitis B during our forecast period.

  • Hepatitis
  • Pathology
  • United States
  • World
  • Market Size
  • Hepatitis B
  • HEPATITIS B

Abbott Diagnostics is one of the leading vendors in the global hepatitis B and C diagnostics market.

  • Hepatitis
  • World
  • Market Size
  • QIAGEN N.V.
  • Roche Group

Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 ##.

  • Hepatitis
  • Pathology
  • Therapy
  • World
  • Market Size
  • HEPATITIS C: KEY METRICS IN THE 9MM
  • SALES FOR HEPATITIS C BY REGION, 2015-2025

VIRAL HEPATITIS; ## (##):##-##.

  • Hepatitis
  • Market Size
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • HEPATITIS C THERAPEUTICS MARKET, GLOBAL, PIPELINE, 2017
  • HEPATITIS C THERAPEUTICS MARKET, COMPARATIVE EFFICACY AND SAFETY HEATMAP FOR MARKETED PRODUCTS FOR HEPATITIS C

CERTAIN-##: Efficacy and Safety of Glecaprevir/ Pibrentasvir in Japanese Patients With Chronic Genotype ## Hepatitis C Virus Infection With and Without Cirrhosis.

  • Hepatitis
  • Market Size
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • HEPATITIS A
  • HEPATITIS B

The most common hepatitis is viral hepatitis, which can be caused by one of five hepatotropic viruses: hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E.

  • Hepatitis
  • Market Size
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson

## North America Hepatitis Diagnostics Market, by Test Type, 2014 - 2025 (USD Million) TABLE ## North America Hepatitis Diagnostics Market, by Blood Tests Market, 2014 - 2025 (USD Million) TABLE ## U. S. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Mil

  • Diagnostics
  • Hepatitis
  • Pathology
  • United States
  • Market Size

## North America Hepatitis Diagnostics Market, by Test Type, 2014 - 2025 (USD Million) TABLE ## North America Hepatitis Diagnostics Market, by Blood Tests Market, 2014 - 2025 (USD Million) TABLE ## U. S. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Mil

  • Diagnostics
  • Hepatitis
  • Pathology
  • United States
  • Market Size

It is one of the five known human hepatitis viruses (A, B, C, D, and E).

  • Hepatitis
  • Pathology
  • APAC
  • World
  • Market Size
  • SALES FORECASTS ($M) FOR CHRONIC HEPATITIS B THERAPEUTICS IN THE 5EU, 2014-2024
  • SALES FORECASTS ($M) FOR CHRONIC HEPATITIS B THERAPEUTICS IN CHINA, 2014-2024

UA=##& UA=##.

  • Hepatitis
  • Market Size
  • Gilead Sciences, Inc.
  • Novartis AG
  • Roche Group

Hepatitis C Testing Market Diagnostics Sales by Major Supplier

  • Hepatitis
  • Europe
  • Japan
  • United States
  • Market Size

Hepatitis C Testing Market Diagnostics Sales by Major Supplier

  • Hepatitis
  • Europe
  • Japan
  • United States
  • Market Size
  • presents the global sales of chronic hepatitis B therapeutics, divided by therapy class.
  • SALES FORECASTS ($M) FOR CHRONIC HEPATITIS B THERAPEUTICS IN THE US, 2014-2024

ua=##& ua=##.

  • Hepatitis
  • United States
  • Market Size
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • GLOBAL HEPATITIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 6.4.2 Global Hepatitis Market Revenue and Forecasts to 2025 (US$ Mn)

APPROXIMATELY ONE IN FIVE PERSON IS DIAGNOSED WITH DIABETES AND NEAR ABOUT ONE THIRD POPULATION IS OBESE.

  • Hepatitis
  • World
  • Market Size
  • Hitachi, Ltd.
  • Neusoft Corporation

Hepatitis C

4385 5000 3900
  • SOVALDI + DAKLINZA HAS BEEN ADOPTED AS THE STANDARD OF CARE FOR GT-3 PATIENTS IN ALL EU MARKETS EXCEPT FOR THE UK
  • ELECTRON-2 DATA AND LOWER COST HAVE DRIVEN HARVONI'S UPTAKE AS AN ALTERNATIVE TO SOVALDI + DAKLINZA IN THE US AND EU

Journal of Viral Hepatitis, ##(Suppl ##), ##-## < DOI> ##. ##/ jvh. ##< / DOI>.

  • Hepatitis
  • European Union
  • Japan
  • United States
  • Market Size
  • presents the global sales of chronic hepatitis B therapeutics, divided by therapy class.
  • SALES FORECASTS ($M) FOR CHRONIC HEPATITIS B THERAPEUTICS IN CHINA, 2014-2024

ua=##& ua=##.

  • Hepatitis
  • China
  • Market Size
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • presents the global sales of chronic hepatitis B therapeutics, divided by therapy class.
  • SALES FORECASTS ($M) FOR CHRONIC HEPATITIS B THERAPEUTICS IN JAPAN, 2014-2024

ua=##& ua=##.

  • Hepatitis
  • Japan
  • Market Size
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • HEPATITIS C THERAPEUTICS MARKET, GLOBAL, FIRST-IN-CLASS
  • HEPATITIS C THERAPEUTICS MARKET, RISK FACTORS FOR FIBROSIS

DISCOVERY OF ANTI-CLAUDIN-## ANTIBODIES AS CANDIDATE THERAPEUTICS AGAINST HEPATITIS C VIRUS.

  • Hepatitis
  • Market Size
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.

Hepatitis C Testing Market Diagnostics Sales by Major Supplier

  • Diagnostics
  • Hepatitis
  • Market Size
  • Hepatitis B Immune Globulin Major Producer and Their
  • Hepatitis B Immune Globulin Export Volume and

BLOOD PRODUCTS INDUSTRY ASSESSMENTS Chart ##: China' s Key Blood Products Producer Location by Province Chapter III ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Hepatitis
  • China
  • Market Size
  • Chengdu Ronsen Pharmaceutical Co., Ltd.
  • Hualan Biological Engineering Co., Ltd.
  • Hepatitis B Immune Globulin Import Volume and
  • Hepatitis B Immune Globulin Major Producer and Their

The auto exports exceeded over ## million each year.

  • Hepatitis
  • China
  • Market Size
  • Chengdu Ronsen Pharmaceutical Co., Ltd.
  • Hualan Biological Engineering Co., Ltd.
  • PRESENTS THE GLOBAL SALES OF CHRONIC HEPATITIS B THERAPEUTICS, DIVIDED BY THERAPY CLASS.
  • SALES FOR CHRONIC HEPATITIS B THERAPEUTICS BY COUNTRY, 2014-2024

UA=##& UA=##.

  • Hepatitis
  • Market Size
  • Gilead Sciences, Inc.
  • Novartis AG
  • Roche Group
  • SALES FORECASTS ($M) FOR CHRONIC HEPATITIS B THERAPEUTICS IN THE 5EU, 2014-2024
  • presents the global sales of chronic hepatitis B therapeutics, divided by therapy class.

ua=##& ua=##.

  • Hepatitis
  • World
  • Market Size
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.

Hepatitis C Testing Market Diagnostics Sales by Major Supplier

  • Diagnostics
  • Hepatitis
  • Market Size

Emerging Diagnostic Technologies ##.

  • Diagnostics
  • Hepatitis
  • France
  • Germany
  • Market Size
  • Global hepatitis therapeutics market
  • GLOBAL HEPATITIS A THERAPEUTICS MARKET

Genotype ## is the most common hepatitis C virus.

  • Hepatitis
  • Market Size
  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.

is mainly suitable for curing hepatitis B and hepatitis C, while IFN-?

  • Hepatitis
  • Interferon
  • Medical Biotechnology
  • China
  • Market Size
  • CANCER VACCINES MARKET, GLOBAL, ANNUAL REVENUE FORECAST FOR HEPATITIS B SURFACE ANTIGEN
  • Preregistration

Recombinant Hepatitis B Vaccine (Engerix-B®).

  • Hepatitis
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • CHINA HEPATOCELLULAR CARCINOMA (HCC) MARKET BY VALUE; 2018-2022 (US$ MILLION)
  • 4.3 CHINA PD-1 AND PD-L1 INHIBITORS MARKET: CANCER ANALYSIS

The major causes of HCC in China are hepatitis B and hepatitis C infection, alcohol consumption, aflatoxin exposure and tobacco smoking.

  • Hepatitis
  • China
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company